Global Medical Affairs Leader; GMAL), Prostate Cancer

Global Medical Affairs Leader (GMAL), Prostate Cancer

2 days ago Be among the first 25 applicants

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and Med Tech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.

Learn more at

Our Oncology team is focused on the elimination of cancer by discovering new pathways and modalities to find treatments and cures. We lead where medicine is going and need innovators with an unwavering commitment to results. Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way. Learn more at

We are searching for the best talent for the Global Medical Affairs Leader (GMAL), Prostate Cancer to be in Raritan, NJ.

The Global Medical Affairs Leader (GMAL), Prostate Cancer, is responsible for leading the execution of medical affairs strategy for the clinical-commercial optimization of product development and life cycle management. The current role focuses on Localized Prostate Cancer. GMAL also contributes to strategies and plans for multiple products and/or compounds within the disease area stronghold (DAS) and/or therapeutic area (TA).

GMAL will partner closely with several cross‑functional and cross‑regional stakeholders including the Regional Medical TA/product leaders, global commercial and market access leaders, Clinical Development Leaders, Compound Development Leaders, other R&D colleagues, GMA Operations Leader, etc., to develop integrated global medical affairs perspectives, strategies, and plans.

• Contribute to the development and lead the execution of the Global Medical Affairs (GMAF) strategy and plan for the assigned compounds based on prioritized global and regional needs.
• Collaborate with the Compound Development Team(s) (CDT) to ensure integration with the overall global compound strategy, resulting in one global R&D and Medical Affairs compound development plan, inclusive of developing a Target Product Profile representing medical affairs global and regional value needs.
• Lead relevant external engagement and patient advocacy initiatives/strategy by driving, building and enhancing strategic alliances with key national and international stakeholders, including patient advocacy groups, physician advocacy groups, academic organizations and other relevant stakeholders in response to patient needs and in support of Janssen’s global patient advocacy objectives and related strategic goals responsibility for JNJ’s patient advocacy landscape assessment and engagement strategy.
• Lead the asset specific cross regional medical affairs strategic discussions (W‑MAST) and cross regional knowledge transfer and scientific exchange meetings (WISE), consisting of regionally designated Therapeutic Area Medical Affairs Leaders to create one medical affairs perspective and one “unified” voice on the CDT.
• Provide single Medical Affairs voice into the creation of compound development and strategies, plans and trial design from phase IIa through phase IV.
• Lead execution of the pre-launch medical activities including product/Therapeutic Area global advisory boards, medical symposia and congress activities, coordination of regional activity in these areas.
• Collaborate closely with the regional medical affairs representatives to develop integrated global medical affairs strategies and plans and maintain open, two‑way communication to ensure regional medical affairs is up to date on all plans, progress and decisions.
• Lead development and execution of the global publication plan as well as review and approval of publications and scientific congress displays for marketed products and specified compounds in clinical development.
• Manage the ReCAP process (review of all medical affairs sponsored clinical…